Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07213726 · ClinicalTrials.gov registry record · NA
Quantification of Progenitor Cell Circulation Following Vascular Resistance Exercise Using Delfi Tourniquet System
A NA study of Blood Flow Restriction (BFR) Training Effects, sponsored by Andrews Research & Education Foundation.
- Active
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT07213726: Active NA study of Blood Flow Restriction (BFR) Training Effects, sponsored by Andrews Research & Education Foundation.
NCT07213726 is a NA study of Blood Flow Restriction (BFR) Training Effects that is active but no longer recruiting, run by Andrews Research & Education Foundation. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07213726, a NA study of Blood Flow Restriction (BFR) Training Effects, is active but no longer recruiting, sponsored by Andrews Research & Education Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this observational study is to examine how slowing down blood flow to the legs- a practice called blood flow restriction (BFR)- during exercise by applying compression to the legs affects the way stem cells are released into the blood stream. This will be determined by drawing 6 cubic centimeters (ccs) of blood immediately post-exercise after the Delfi Personalized Tourniquet System (PTS) has been removed. 6 ccs of blood will also be taken prior to exercise and at the 20-, 40-, and 60-minute marks after exercise. The main question of this study is: • Will the levels of stem cells extracted before and after exercise be the same if blood flow is restricted during exercise? In this study, participants will undergo the following: * 6 ccs of blood extracted from the forearm prior to exercise to establish a baseline * 3 exercises- seated leg extension, semi-reclined leg press, and seated hamstring curl- consisting of 4 sets of 30-15-15-15 repetitions per exercise; resistance will be set to 30% of one-rep maximum (1-RM) * Additional 6 cc blood draws will be performed immediately post-exercise and after 20, 40, and 60 minutes have elapsed
Primary Outcome
Allows researchers insight into each subject's exertion level reflected by the amount of lactate found within the samples collected.
Conditions Studied
Interventions
- DEVICE Delfi Personalized Tourniquet System
Study Locations (1)
Florida
- Andrews Institute for Orthopaedics & Sports Medicine - Gulf Breeze
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-08-16 |
| Est. Completion | 2026-11-20 |
| Phase | NA |
What the registry record for NCT07213726 still lists
NCT07213726 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Blood Flow Restriction (BFR) Training Effects appearing as the primary indexed condition, and to 1 intervention - of which Delfi Personalized Tourniquet System is the first listed.
NCT07213726 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07213726 about?
NCT07213726 is a clinical study titled "Quantification of Progenitor Cell Circulation Following Vascular Resistance Exercise Using Delfi Tourniquet System". The purpose of this observational study is to examine how slowing down blood flow to the legs- a practice called blood flow restriction (BFR)- during exercise by applying compression to the legs affects the way stem cells are released into the blood stream. This will be determined by drawing 6 cubic...
What is the current status of trial NCT07213726?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2022-08-16. Estimated completion is 2026-11-20.
What conditions does trial NCT07213726 study?
This clinical trial studies the following conditions: Blood Flow Restriction (BFR) Training Effects.
What interventions are being tested in trial NCT07213726?
The interventions under investigation include: Delfi Personalized Tourniquet System (DEVICE).
Who is sponsoring clinical trial NCT07213726?
This trial is sponsored by Andrews Research & Education Foundation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07213726 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07213726's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI